Professional and Commercial Equipment and Supplies Merchant Wholesalers (U.S., NAICS 4234)

A Histometrics rollup primer for public-market and private investors. This page synthesizes the seven child industries into one view: where the money is, how the economics differ, and who owns what.

NAICS (the North American Industry Classification System) is the standard the U.S. federal statistical agencies use to group businesses. Code 4234 is a four-digit industry group — one level below the two-digit sector (42, Wholesale Trade) and one level above the five-digit industries. It bundles seven distinct distribution businesses that share one job: buying professional and commercial equipment in bulk from manufacturers and reselling it to the businesses that use it.

1. Overview

Every child in 4234 is a merchant wholesaler — a distributor that takes title to goods (buys and owns the inventory) and resells it for its own account, as opposed to an agent or broker that only arranges sales for a commission. These firms sit in the middle of the channel: between the factory and the end user. When a hospital stocks surgical supplies, a company buys 500 laptops, a restaurant outfits a kitchen, an optometrist orders contact lenses, or a research lab reorders reagents, the goods almost always pass through a distributor in this group first.[1] The dependence is measurable at the biggest end: roughly 90% of U.S. hospitals buy through commercial distributors rather than self-distributing.[4]

For an investor, 4234 is a picks-and-shovels bet on professional and commercial activity across the whole economy — corporate IT spending, healthcare utilization, restaurant and retail buildout, scientific research, and eyewear demand — without wagering on any single product or brand. The economics are uniform in shape: thin spreads, high inventory throughput, working-capital intensity, and profit that comes from velocity, vendor rebates, and a shift toward higher-margin services and consumables rather than from markup. What differs — dramatically — is the end market, and that is what this rollup is about. Some children are defensive and growing (medical, ophthalmic); one is the group's growth engine (computers/IT); one is structurally declining (office machines); one has a shrunken but now-stabilizing core (photographic); one is cyclical (foodservice equipment).[1][3][4][9]

The group as a whole is large — roughly $766 billion in receipts — but that headline hides three things: two of the seven children account for roughly 82–84% of the dollars, one child's receipts are not published at all, and the group-level competition figures are a statistical mirage.

2. What's inside — the seven children and how they differ

The seven five-digit children of 4234 do not compete with one another; a copier distributor and a contact-lens distributor share a NAICS branch but not a customer. The distinctive value of this level is the contrast across them. Note the split personality below: the industry that leads on revenue (computers) is not the one that leads on employment (medical), because expensive hardware passes through on far fewer hands than clinical supply does.

*VAD = value-added distributor. †POS = point-of-sale register. ‡ATM = automated teller machine. §ADR = American Depositary Receipt (U.S.-traded stand-in for a foreign share). Revenue shares from the 2022 Economic Census; job shares from County Business Patterns 2023.[1][2] Child figures from the seven child primers.[3][4][5][6][7][8][9]

Three contrasts worth internalizing:

• Two children are the industry group. Computers (~42–43%) and medical (40.6%) together hold roughly 82–84% of receipts. The four small children that publish receipts — office, foodservice, lab/professional, and ophthalmic — hold about 40% of the group's firms (7,735 of 19,491) for roughly 15% of the dollars; photographic's dollar share is unmeasured but small, at 1.0% of the group's jobs. This is a two-giants-plus-a-long-tail structure.[1][3][4][5][6][7][8][9]
• Revenue per worker diverges three- to four-fold. Computer distribution moves roughly $1.6–1.7 million of sales per employee — pricey hardware passing through on a thin markup with little handling. Office-machine distribution moves only about $0.4–0.5 million per employee (the range reflects a genuine dispute over that child's headcount, below), because its real business is service: technicians, cost-per-page contracts, and installed-base maintenance, not box-moving. Medical sits near $1.1 million, reflecting a large, well-paid clinical/sales force. Photographic can no longer be placed on this scale at all, because its sales are suppressed.[1][2][3][6][9]
• Direction of travel splits the group. Growth engines (computers, medical, ophthalmic, long-run lab) versus a structural decliner (office machines) versus a cyclical middle (foodservice) versus photographic, whose collapse has already happened — global camera shipments fell from 121.5 million units in 2010 to 9.44 million in 2025, but that 2025 figure was up 11.2% year over year, with interchangeable-lens units up 2.8%. A buyer of "wholesale trade" as a theme is buying a barbell of secular winners, one secular loser, and a shrunken survivor.[3][4][5][6][7][8][9]

3. Size — the group's rollup figures

These are our ground-truth federal statistics for NAICS 4234.[1][2]

The children reconcile on bodies but no longer on dollars — that is new. Summing the seven child primers' establishments gives exactly 29,863, and their employment gives exactly 670,408, matching the group totals to the unit — a clean integrity check on the physical measures.[2][3][4][5][6][7][8][9] Receipts no longer reconcile, because two children moved this pass. The photographic child's re-check found that the Census suppresses sales, cost of goods sold, and gross margin entirely at that code to protect individual companies; the only substantial scale measure published is ~$5.58 billion of purchases, which is what the channel bought, not what it sold.[9] And the computer child's re-check found that different 2022 Economic Census tables disagree — the margin-and-profit table reports $319.4 billion where summary tables report $331.3 billion — so the honest figure is a band of $319–331 billion, not the single number this page previously carried.[3] The group's $766.5 billion still stands as its own audited total; it simply can no longer be tied back to a tidy sum of seven child receipts.

The group's average pay is high for wholesale/logistics work — it reflects skilled, commission-earning sales forces and technical/clinical support staff alongside warehouse labor, not a low-wage picking operation. The children now let you see the dispersion behind that average: medical pays roughly $125,000 per worker, lab/professional ~$101,000, photographic ~$96,000, office machines ~$78,000, and ophthalmic ~$77,000. Pay tracks how technical the sale is, not how expensive the box.[2][4][5][6][8][9]

One employment figure is contested. Office equipment's headcount is reported at 83,163 by County Business Patterns for 2023 but at 66,100 by the BLS March 2025 benchmark — a 20% gap reflecting different methodologies and periods, with the newer, lower series still being revised down. BLS also discontinued that child's wage and hours series in February 2024, substituting the broader NAICS 4234 grouping.[6] The group totals above use the CBP basis throughout.

The concentration numbers are a statistical illusion — read this carefully. At the group level the four-firm concentration ratio (CR4, the share of revenue held by the top four firms) is just 15.2%, the top eight hold 24.3%, the top 20 hold 42.9%, the top 50 hold 59.5%, and the Herfindahl-Hirschman Index (HHI, a standard 0–10,000 antitrust gauge where under 1,500 is "unconcentrated") is a rock-bottom 133.7.[1] Taken at face value this looks like one of the most competitive industries in America. It is not. The group HHI is lower than every one of the six children that publish one — because averaging across markets that don't compete manufactures the appearance of competition. Those six run from 151.3 (foodservice) to 581.9 (office equipment), with computers at 462.3, ophthalmic at 457.5, lab/professional at 517, and medical at 273.9; the seventh, photographic, publishes no CR4 or HHI at all, so any "top four = X%" claim for that child is unsupported by federal data.[3][4][5][6][7][8][9] Office equipment now carries both the highest published CR4 (40.5%) and the highest published HHI in the group.[6]

The true competitive arenas are tighter than any of those numbers. Computer distribution is a national duopoly (TD SYNNEX and Ingram Micro) — visible from the customer side in Connection's filings, where TD SYNNEX, Ingram Micro, and Microsoft supplied about 25%, 21%, and 13% of 2025 product purchases. Hospital med-surg is an oligopoly (Medline, McKesson Medical-Surgical, Cardinal Health, Concordance), dental a duopoly (Henry Schein and Patterson), and broad-line lab supply a duopoly (Fisher Scientific and VWR). Foodservice makes the point most sharply: a Census CR4 of 19.3% sits alongside a trade-press count in which the top 100 dealers did $16.49 billion of 2025 sales and five firms held more than half of that. The two are not in conflict — one measures a broad statistical category, the other a narrow commercial channel.[3][4][5][7] Never read the group's HHI as the level of real competition; read the children, and then read the channel inside the child.

Undercount caveat. The $766 billion understates the economic footprint of these products for reasons every child primer flags. (1) Manufacturer-direct sales bypass this layer and are counted under manufacturing — most of Xerox/Canon/HP office-machine volume, the vertically integrated eyewear giants (EssilorLuxottica, Alcon, CooperVision), and camera makers' captive U.S. arms book their distribution under manufacturing codes, not here.[6][8][9] (2) E-commerce and services leak into other codes — the foodservice channel's largest player, Clark Associates (WebstaurantStore), is itself sized differently by different sources, at roughly $4.0 billion of 2025 sales by the trade press versus about $5.3 billion in an earlier Forbes estimate, and on either figure much of that online revenue likely books under electronic-shopping codes rather than here; the recurring toner/service and reagent revenue that is the real profit engine in office and lab distribution often files under repair or services.[5][7] (3) Small and family-owned firms dominate the long tail, where a distributor may file under a retail or services primary code — an office-technology dealer survey covering 415 respondents, roughly a fifth of U.S. independents, found $6.9 billion of 2024 revenue in that sample alone.[6] Treat the Census figure as an audited floor on the distribution activity, not a ceiling on the products' economy.[1]

4. Investable universe — where value concentrates across the children

Because value concentrates in two children, and because those are precisely where listed pure-plays exist, the public-market map is unusually clean: the ~82–84% of group revenue in computers and medical is largely investable through listed companies; the rest is mostly not. (Tickers and scale are reserved for this section per house style.)

Where you can own it directly (public pure-plays):

• Computers/IT (42343) — the deepest public bench: TD SYNNEX (SNX, ~$62.5 billion of FY2025 revenue) and Ingram Micro (INGM, ~$52.6 billion FY2025) are the two large broad-line distributors; ScanSource (SCSC, ~$3.0 billion) and Climb Global Solutions (CLMB, ~$0.7 billion) are small-cap specialists. Adjacent value-added resellers CDW (CDW, ~$21.0 billion), Insight Enterprises (NSIT), and Connection (CNXN), plus component distributors Arrow (ARW) and Avnet (AVT), are close cousins. Two cautions the child now insists on: those company figures are global while the Census total is U.S.-only, and headline revenue is not comparable across firms — TD SYNNEX reported $89.4 billion of gross billings against $62.5 billion of recognized revenue, because some cloud and software transactions book net as agency revenue.[3]
• Medical (42345) — Medline (MDLN, ~$28.4 billion of 2025 net sales; the biggest initial public offering of 2025, raising $6.26 billion in December 2025 at a market value above $50 billion, with an insider lock-up running into mid-2026) and Henry Schein (HSIC, whose ~$11.1 billion distribution segment splits $6.9 billion dental and $4.3 billion medical) are the near-pure-plays; diversified exposure runs through the pharma-led giants Cardinal Health (CAH, medical segment ~$12.6 billion of a ~$227 billion company), McKesson (MCK), and Cencora (COR). Two adjacent routes are worth knowing: Premier (PINC) is exposure to the group-purchasing side of the table rather than distribution, and the listed remainder of Owens & Minor, renamed Accendra Health (ACH), is now essentially a home-medical-equipment company holding a 5% interest in the distribution arm it sold.[4]
• Lab/professional (42349) — Avantor (AVTR, owner of VWR; $6.552 billion of FY2025 revenue, of which Laboratory Solutions was $4.4 billion) is the one listed pure-play on the distribution layer, and it is explicitly a turnaround rather than a compounder — declining revenue, an activist involved, a new chief executive since August 2025, and a ~$400 million cost program. Thermo Fisher (TMO, owner of Fisher Scientific) offers the exposure inside a diversified franchise, though its $23.984 billion Laboratory Products & Biopharma Services segment also contains contract manufacturing and clinical research and is far broader than distribution.[5]

Where public access is indirect or absent:

• Foodservice (42344) — this changed. Sysco (SYY) acquired Edward Don, a top-five dealer, for $969 million in 2023, and its purchase of Restaurant Depot is pending review — so one of the channel's leaders now sits inside a listed company, albeit diluted to about 2% of Sysco's ~$81.4 billion of FY2025 revenue. Global Industrial (GIC) and UK-listed serial acquirer Bunzl (BNZL) remain the closest distributor proxies; most investors still use demand proxies like Middleby (MIDD), ITW, US Foods, and Performance Food Group.[7]
• Ophthalmic (42346) — no listed pure-play wholesaler; exposure runs through vertically integrated maker-distributors, mostly foreign and accessed via ADRs. The broadest single proxy, EssilorLuxottica, earns roughly 47% of group revenue from its wholesale segment, so these proxies are genuinely half-distribution businesses rather than pure manufacturers.[8]
• Office machines (42342) and photographic (42341) — no listed pure-play in either, and the office set is thinning rather than growing: the largest office-products distributor with any adjacency was taken private in December 2025 in an approximately $1 billion transaction. Photographic exposure runs only through diversified manufacturers (Sony, Canon — Tokyo-listed with ADRs trading over-the-counter since its 2023 NYSE delisting — Fujifilm, Nikon), brand owners that are not wholesalers (GoPro, Videndum), or broad-line distributors where imaging is a rounding error.[6][9]

Where the industry is actually owned: private equity and family firms. Across all seven children, most of the money is private. PE controls or built the leaders in nearly every niche — Platinum Equity controls Ingram Micro with roughly 90% voting power post-IPO and Apollo assembled TD SYNNEX (computers); Patient Square took Patterson private for about $4.1 billion, Platinum bought the Owens & Minor distribution arm for $375 million, and in June 2026 Apollo-managed funds paid $1.25 billion for roughly 13% of McKesson Medical-Surgical, implying about a $13 billion enterprise value for that unit (medical/dental); TriMark is creditor-owned since its 2023 restructuring and Singer is a PE roll-up (foodservice); Covetrus, Patterson, and School Specialty are PE-owned (lab/vet/school); and the largest independent contact-lens distributor is PE-owned (ophthalmic).[3][4][5][7][8] One useful counterexample against reading this as PE-only: D&H Distributing, a significant broad-line computer competitor, is structured as an employee stock ownership plan.[3] With ~19,500 firms — most small, many family-run with aging owners, and SBA small-business thresholds running from 100 employees (foodservice) to 250 (computers) — this is a private-markets and roll-up universe first, a stock market one second.[1][10]

5. How the money works

Every child runs the same engine — spread and velocity, not markup — with the same profit levers, which is what makes 4234 a coherent group despite its unrelated end markets. Owners earn the difference between the manufacturer's price and the resale price, multiplied by how fast they turn inventory. Because inventory and receivables tie up cash, the business is working-capital intensive, and over-leverage is the recurring failure mode (foodservice roll-up TriMark's 2023 creditor takeover is the cautionary tale).[7] The metrics that matter are distribution metrics — gross margin %, inventory turnover / days sales of inventory, gross-margin return on inventory, and the cash-conversion cycle — not retail's same-store sales.[1]

The spread is not uniform across the group; it tracks how much work the distributor does. The children now let you rank it. Pure box-moving at national scale earns least: broad-line computer distributors run ~6–7% gross margin and about 2% operating margin, and Cardinal Health's medical segment returned roughly 1.1% segment-profit margin in fiscal 2025.[3][4] Doing more work pays more: computer specialists earn ~13.4% gross; foodservice dealers run about 23.1% gross and 3.9% pretax; broad-line lab distribution earns roughly 11.6% adjusted operating margin on a 32.7% gross margin; and value-added distribution into small dental, physician, and veterinary practices runs mid-20s to low-30s percent gross.[3][4][5][7]

A measurement warning that now applies group-wide. Four children independently flag that Census margin constructs are not company margins. The Census reports gross margins of roughly 27% for computer distribution, 48.7% for office equipment, 42% for ophthalmic, and 31.3% on the foodservice subline — against GAAP gross margins in those businesses that are a fraction of those numbers. Census's "gross profit" line is gross margin plus commissions minus operating expenses, and is not GAAP gross profit, EBIT, EBITDA, or net income.[3][6][7][8] Do not read either figure as distributor profitability.

Four levers separate winners from losers, and each child leans on a different one:

• Recurring revenue beats hardware markup. The razor-and-blades pattern is everywhere: cost-per-page service contracts on copiers, where practitioners put gross margins near 47.5% at 2 cents per page and ~58% at 2.5 cents, well above the hardware; reagents and consumables that reorder continuously — 95% of Patterson's fiscal-2024 Animal Health segment sales were consumables against 3% equipment; daily-disposable contact-lens reorders; and toner and parts. One vertically integrated imaging maker took only $1.5 billion of its $6.3 billion 2025 print revenue from equipment, and $4.8 billion from post-sale service, supplies, rentals, and financing.[5][6][4][8]
• Vendor rebates and incentives make or break the year. Volume-tiered rebates and co-op marketing dollars from manufacturers are often the difference between a profitable and unprofitable distributor — most acute in computers (thin ~2% operating margins), ophthalmic, and photographic.[3][8][9]
• Private-label / own-brand is the margin escalator — but it is manufacturing profit, not distribution profit. Medline's 12.2% adjusted EBITDA margin looks like a different business partly because it is: roughly a third of its Medline-brand products are self-manufactured, so that figure blends manufacturing with distribution. Avantor makes the same point in reverse — its bioprocessing-materials segment earns about 26% adjusted operating margin against ~11.6% in lab distribution. The richest profits in this group sit closer to the factory than to the resale.[4][5]
• Operating discipline, not pricing. The clearest evidence is the foodservice benchmarking data: typical dealers and high-profit dealers run essentially the same gross margin (23.1% versus 23.3%) but roughly double the pretax margin (3.9% versus 8.2%). The gap is payroll at 11.9% of sales versus 10.0%, other expenses 7.4% versus 5.3%, inventory turns of 4.9 versus 4.3, and receivables collected in 28.1 days versus 36.3. That is the whole thesis of this group in one table: the winners do not charge more, they run tighter.[7]

Financing and mix sit on top: most copiers are placed on 3–5-year leases, making office distribution quietly interest-rate sensitive, and across the group a shift toward services, used/refurbished gear, and advanced solutions lifts blended margins.[6][3] The persistent threat to all of it is disintermediation: when a manufacturer sells direct to a large customer, or a hyperscaler/e-commerce marketplace buys at near-manufacturer prices, the middleman's spread disappears.[3][7]

6. Demand drivers

Because the seven children serve different end markets, the group's aggregate demand is naturally diversified and partly self-hedging — a downturn in discretionary IT or restaurant capex can be cushioned by defensive healthcare and eyewear demand.

• Business IT spending and technology cycles (computers) — the PC refresh (Windows 10 support ended October 14, 2025, forcing a large corporate refresh and lifting worldwide PC shipments ~9% in 2025 to more than 270 million units), AI data-center infrastructure, AI PCs at an estimated ~31% of device shipments, the cloud/subscription shift, and cybersecurity. The group's biggest single growth engine — but the children now force a correction the parent previously missed: AI is not automatically a margin upgrade for distributors. Ingram Micro's fiscal-2025 AI-enablement server volume added growth while diluting gross margin, because those are lower-margin, lower-cost-to-serve transactions. The attractive economics sit in the configuration, networking, security, financing, and managed services wrapped around the hardware, not in the boxes.[3]
• Healthcare utilization (medical, ophthalmic) — U.S. health spending reached ~$4.9 trillion (17.6% of GDP) in 2023 and is projected to grow 5.4% a year through 2034 against 4.1% nominal GDP growth, taking health spending from 18.0% of GDP in 2024 to 20.6% in 2034. Hospital medical-and-surgical supply costs alone rose from about $40 billion to $57 billion between 2020 and 2025. The mix is shifting under the total: channel data for 2025 show distributor sales up 5.1% to hospitals and 2.3% to physician practices but 9.3% to home care and 12.6% to treatment centers — which changes which distributors win while keeping aggregate demand rising. On the eyewear side, about 250 million U.S. adults (94%) regularly use some form of eyewear.[4][8]
• Restaurant, retail, and institutional foodservice (foodservice equipment) — the National Restaurant Association projects about $1.55 trillion of 2026 sales across more than a million outlets, with equipment replacement cycles and retail construction on top. The cyclicality is no longer theoretical: Middleby's domestic commercial-foodservice sales fell 1.4% in 2025 on weaker replacement demand, and ITW reported institutional growth offset by softer independent-restaurant and food-retail demand. The supplies-and-replacement base is steadier than the project base.[7]
• Research, testing, education, and animal care (lab/professional) — U.S. R&D performance totaled $937 billion in 2023, with higher-education R&D at $108.7 billion in fiscal 2023 (HHS, including NIH, supplying $33.1 billion). Federal funding is the major swing factor, and 2025 brought sharp cuts: more than 3,800 NIH grants terminated or frozen and a proposed ~40% budget reduction — a live headwind into 2026. Offsetting it: biopharma onshoring, infrastructure spending for geospatial, and pet health, where U.S. pet spending reached $158 billion in 2024 including $41.0 billion of veterinary care.[5]
• The offsetting headwinds. Office print volume is the group's clearest structural decline — offices in mature economies cut print roughly 20% between 2020 and 2025, 35% of employed people work from home on an average day, and USPS First-Class Mail fell 5.0% (2.2 billion pieces) in fiscal 2025. Photographic's decline, by contrast, has largely already happened. Ophthalmic shows a third pattern: in 2025 the U.S. optical market grew in dollars to $69.5 billion even as unit volume and eye exams declined — price and mix, not traffic, carried growth.[6][9][8]

7. Regulation

There is no federal license to be a merchant wholesaler in any of these children; the regulatory load falls on the goods that flow through the channel, and it varies sharply by child:

• Product safety and medical-device rules — the FDA regulates medical devices, including Unique Device Identification, recall, and postmarket tracking duties; note that the pharmaceutical track-and-trace regime (DSCSA) applies to drugs, not most devices, a common point of confusion. In ophthalmic, contact lenses and solutions are regulated devices, and so, less obviously, are spectacle lenses, frames, and sunglasses, which must meet the impact-resistance requirement in 21 CFR 801.410. NSF/ANSI sanitation, UL/ETL electrical, ENERGY STAR/DOE efficiency standards, and the FDA Food Code govern foodservice equipment.[4][8][7]
• Prescription-release and channel-access rules — the FTC Contact Lens Rule enables mail-order lens sales, and the FTC's updated Eyeglass Rule (2024) extends comparable automatic prescription release to spectacles, adding recordkeeping duties for financially interested prescribers. Both help independent and online sellers at the expense of integrated practices.[8]
• Data security — copiers store scanned images on internal drives, triggering HIPAA/GLBA/FTC data-disposal duties on end-of-lease devices (office).[6]
• Trade and export controls — Export Administration Regulations (enforced by the Bureau of Industry and Security) on advanced computing and dual-use lab instruments; NDAA Section 889 and FCC action barring Hikvision/Dahua surveillance gear, forcing distributors to certify NDAA-compliant product (photographic); FAA Remote ID and Part 107 for drones; hazardous-materials transport and DEA registration for reagents (lab).[3][5][9]
• Environmental transitions — EPA's HFC rules restrict higher-global-warming-potential refrigerants with phased compliance beginning in 2025, bringing training requirements, parts complexity, and the risk that legacy foodservice inventory ages badly; e-waste and TSCA rules bear on office-machine remarketing.[7][6]
• The universal live issue: tariffs. Nearly all hardware in every child is imported, so the 2025 trade escalation raised landed costs across the entire group — the one regulatory theme that touches all seven children at once. It is now quantified rather than assumed: Medline disclosed an approximately $290 million adverse impact to 2025 pretax income with ~$200 million more expected in 2026; Section 301 duties on syringes and needles reached 100% in 2024 with gloves scheduled to 50% in 2025 and 100% in 2026; a 50% Section 232 rate on certain steel- and aluminum-containing appliances took effect in June 2025; and even non-China sourcing is exposed, with GoPro's Thailand- and Malaysia-made U.S. cameras seeing tariffs rise from 10% to 19% in August 2025.[4][7][9][3][6]

The net burden is a compliance cost and a modest barrier to entry, not rate regulation or a cap on returns — this group has no utility-style rate base, no reimbursement body setting its prices, and no franchise protection. The one partial exception is medical, where CMS reimbursement policy indirectly sets the price and volume ceiling for provider-facing and home-medical business.[4]

8. Consolidation

The dominant M&A story is still private equity rolling up a fragmented base of cash-generative, aging-owner independents, while scale concentrates within each niche into a barbell. But this pass adds a second force the parent previously understated: strategic and vertically integrated acquirers are now buying the channel too. Sysco's $969 million purchase of Edward Don pulled a top-five foodservice dealer inside a public food distributor, with Restaurant Depot pending; Cencora agreed in February 2026 to combine MWI Animal Health with Covetrus, valuing MWI at $3.5 billion and contemplating a 34.3% retained stake; VSP Vision — itself a major vision insurer — completed its acquisition of frame maker Marcolin in December 2025; and Xerox closed its roughly $1.5 billion Lexmark combination in July 2025, folding two declining print franchises together.[7][5][8][6]

The PE and public-market churn continued alongside it. Apollo built TD SYNNEX and Platinum took Ingram Micro private then re-listed it (computers); a 2025 wave crested in medical/dental with Medline's $6.26 billion IPO, Patterson's ~$4.1 billion take-private, and the sale of Owens & Minor's ~$10.7 billion distribution segment to Platinum for $375 million, followed by Apollo's minority purchase in McKesson Medical-Surgical; PE-backed TriMark and Singer plus serial acquirer Bunzl consolidate foodservice; Covetrus, Patterson, and School Specialty were rolled up in lab/vet/school; and the office-products distributor closest to that channel was taken private for about $1 billion in December 2025.[3][4][5][7][6] The through-line for public investors is uncomfortable: the count of clean listed distribution plays keeps shrinking even as the sector's single biggest name arrived on public markets.

Buying power concentrates too, and asymmetrically. More than 95% of U.S. hospitals purchase through group purchasing organizations estimated to save members roughly 10–18%, and the three largest — Vizient, HealthTrust, and Premier — cover over 75% of that market.[4] The countervailing force is disintermediation and channel compression: manufacturers selling direct, e-commerce marketplaces (Amazon Business, WebstaurantStore) undercutting on commodity product, and hyperscaler cloud marketplaces bypassing software distribution. The strategic response, seen in every child, is to move up the value chain into services, private label, and advanced solutions where relationships, e-procurement lock-in, and inventory depth still beat commodity e-commerce.[3][5][6][7]

9. Risks

The children share a common risk stack, amplified by the thin-margin distribution model:

• Margin fragility — with operating margins often near 2%, small swings in price, freight, mix, or rebates move profits sharply. It is now quantified: Ingram Micro's gross margin fell 51 basis points in fiscal 2025 on mix shift toward lower-margin endpoint products, servers, AI-enablement equipment, large enterprise customers, and Asia-Pacific business.[3]
• Disintermediation — manufacturer-direct selling, e-commerce, hyperscaler marketplaces, and GPO pricing pressure threaten the middleman's spread in every child.[3][5][7][8]
• Working-capital and interest-rate sensitivity — inventory- and receivables-heavy balance sheets are exposed to rate rises and credit stress; leasing-financed placements (office) add direct rate sensitivity.[6]
• Tariff and supply-chain shocks — near-total import dependence exposes the whole group, and fixed-price contracts mean distributors often absorb the hit before they can pass it through.[3][4][6][7][9]
• Customer and vendor concentration — dependence on a few manufacturers (loss of authorized-dealer status can gut a distributor) and on large consolidated buyers and group purchasing organizations that squeeze price.[4][9]
• Cyber risk is operational, not merely informational — a theme two children now raise independently. Ingram Micro disclosed a July 2025 ransomware incident that took systems offline, temporarily impaired its ability to process and ship orders, and cost $6.2 million in fiscal 2025; in lab distribution, customers wire procurement systems straight into distributor platforms, so an outage stops order entry, inventory visibility, invoicing, and regulated-product traceability at once.[3][5]
• Secular decline in the mature children — falling office print volume is structural and not expected to recover, and photographic's consumer base is permanently gone even though its residual is stabilizing.[6][9]
• End-market cyclicality — foodservice and IT capex fall in downturns; research-funding cuts hit the lab niche directly.[7][5]
• Data opacity — a risk the group itself now carries. Photographic's sales and concentration are suppressed outright, computer receipts differ by $12 billion across Census tables, and office employment differs by 20% between CBP and BLS. Investors cannot size or benchmark parts of this group from federal statistics alone.[9][3][6]

10. How to invest & outlook

Public routes. The cleanest listed exposure tracks the two revenue giants: computers (SNX, INGM, plus specialists SCSC/CLMB and cousins CDW/NSIT/CNXN/ARW/AVT) and medical (MDLN, HSIC, plus diversified CAH/MCK/COR and GPO-side PINC), with Avantor (AVTR) the one listed pure-play in lab/professional. Because those children are roughly 82–84% of group revenue, public markets actually capture most of the group's dollars — an unusual feature for wholesale trade. These are low-multiple, cyclical value/GARP names judged on return on invested capital, cash conversion, and mix shift, not growth multiples. The remaining children offer only indirect exposure: Sysco (SYY) is now the only listed owner of a top-five foodservice dealer though equipment is ~2% of its revenue, with GIC and BNZL partial and MIDD/ITW/US Foods/PFG as demand proxies; ophthalmic runs through ADRs of integrated manufacturers; and office and photographic have no pure-play at all.[3][4][5][7][8][6][9]

Private routes. This is fundamentally a private-markets and PE roll-up universe. With ~19,500 firms, most small and many family-owned with retiring owners, the recurring playbook is to buy or build a regional distributor — recurring service/consumable cash flow, sticky contracts, modest declining-or-flat-industry multiples — or to finance the working-capital-heavy channel through equipment leasing and private credit. The middle tier of nearly every child is already PE-controlled, and the long tail is a perennial acquisition supply. Diligence in this group is unusually operational and unusually similar across children: rebate quality and change-of-control terms, inventory aging, receivables and deposits, contract revenue by vintage, renewal and churn, supplier and customer concentration, and tariff pass-through. Normalize gross-versus-net accounting before comparing anything to headline revenue.[3][4][5][6][7][9]

Outlook (forward judgment, not reported fact). The group's aggregate trajectory is modest growth with a widening internal divergence. The two giants pull the average up — computers on AI-infrastructure and refresh demand, medical on durable healthcare utilization — while office machines keep shrinking at low-single-digit rates, foodservice rides the restaurant cycle through a soft 2025, lab absorbs a research-funding headwind into 2026, and photographic settles into a smaller but no-longer-collapsing core. Across all seven, the structural pressures are identical: disintermediation and e-commerce compress the distributor's spread, tariffs raise landed costs, and the durable winners are the scale players who lean on private label, recurring services, and e-procurement lock-in. Two cautions this pass adds: growth volume is not the same as margin — AI hardware grew computer distribution while diluting its gross margin — and the group's richest returns sit closer to manufacturing than to resale. For an investor, 4234 is best understood not as one industry but as a portfolio of distribution businesses sharing one economic engine — buy the child whose end market you believe in, and use the group only as a map of where the dollars and the listed pure-plays actually sit. These are judgments, not guarantees.

For full company-by-company detail, unit economics, and niche-specific outlooks, see the seven child primers: 42341 (photographic), 42342 (office equipment), 42343 (computers & software), 42344 (other commercial/foodservice), 42345 (medical/dental/hospital), 42346 (ophthalmic), 42349 (other professional/lab).

---

Sources

Group-level figures (Section 3) are our ingested federal ground-truth statistics for NAICS 4234; the remaining citations are drawn from the seven child primers and the sources they cite.

1. U.S. Census Bureau, 2022 Economic Census — Concentration by Largest Firms and Selected Statistics, NAICS 4234 (receipts $766.5B; 19,491 firms; CR4 15.2%, CR8 24.3%, CR20 42.9%, CR50 59.5%; HHI 133.7), 2022. https://www.census.gov/programs-surveys/economic-census.html
2. U.S. Census Bureau, County Business Patterns 2023, NAICS 4234 (29,863 establishments; 670,408 employees; annual payroll $78.8B; Q1 payroll $20.4B), 2023. https://www.census.gov/programs-surveys/cbp.html
3. Histometrics child primer 42343 / U.S. Census NAICS 423430 — Computer and Computer Peripheral Equipment and Software Merchant Wholesalers (receipts reported as a $319–331B band across disagreeing 2022 Economic Census tables; 4,057 firms; 193,943 employees; CR4 33.8%, CR8 50%, HHI 462.3; TD SYNNEX FY2025 revenue ~$62.5B on $89.4B gross billings; Ingram Micro FY2025 ~$52.6B, 6.67% gross margin, −51bp mix shift, July 2025 ransomware; D&H ESOP; Windows 10 end of support Oct 14 2025; AI hardware dilutes margin). 2022–2026.
4. Histometrics child primer 42345 / U.S. Census NAICS 423450 — Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (receipts $311.5B; 7,394 firms; 272,209 employees; CR4 23.9%, CR8 40.6%, HHI 273.9; ~90% of hospitals use commercial distributors, >95% use GPOs; Medline 2025 net sales $28.4B, Dec 2025 IPO raised $6.26B, ~$290M 2025 tariff impact; Henry Schein distribution $11.1B; Cardinal medical segment ~$12.6B at ~1.1%; Patterson take-private ~$4.1B; Owens & Minor arm to Platinum for $375M, remainder renamed Accendra Health; Apollo–McKesson Medical-Surgical June 2026; CMS National Health Expenditures). 2022–2026.
5. Histometrics child primer 42349 / U.S. Census NAICS 423490 — Other Professional Equipment and Supplies Merchant Wholesalers (receipts $35.2B; 2,282 firms; 44,956 employees; CR4 37.5%, HHI 517; Avantor FY2025 $6.552B with Laboratory Solutions $4.4B at ~11.6% adj. operating margin vs ~26% bioprocessing; Thermo Fisher LPBS $23.984B; Cencora–Covetrus MWI combination Feb 2026 at $3.5B; 2025 NIH/NSF cuts; U.S. R&D $937B 2023; pet spending $158B). 2022–2026.
6. Histometrics child primer 42342 / U.S. Census NAICS 423420 — Office Equipment Merchant Wholesalers (receipts ~$33.3B; 1,901 firms; employment contested at 83,163 CBP 2023 vs 66,100 BLS March 2025 benchmark; CR4 40.5%, CR8 52.0%, HHI 581.9; cost-per-page service margins ~47.5–58%; market estimated down ~9.8% in 2025 and ~4.8%/yr over the prior five; Xerox–Lexmark ~$1.5B closed July 2025; ODP take-private ~$1B Dec 2025; 415-dealer survey at $6.9B of 2024 revenue). 2022–2026.
7. Histometrics child primer 42344 / U.S. Census NAICS 423440 — Other Commercial Equipment Merchant Wholesalers (receipts $33.0B; 2,693 firms; 49,828 employees; CR4 19.3%, CR8 29.1%, HHI 151.3; restaurant-and-hotel equipment $25.6B vs store equipment $6.0B; FE&S top-100 dealers $16.49B in 2025 with top five >half; Clark Associates sized at ~$4.0B by FE&S vs ~$5.3B by Forbes; Sysco–Edward Don $969M; FEDA 2024 benchmarking; National Restaurant Association ~$1.55T 2026 forecast; Middleway/ITW 2025 softness; EPA HFC and Section 232 tariffs). 2022–2026.
8. Histometrics child primer 42346 / U.S. Census NAICS 423460 — Ophthalmic Goods Merchant Wholesalers (receipts $12.7B; 859 firms; 19,689 employees; CR4 ~37%, CR8 ~51%, HHI 457.5; Census gross margin 42%; vertically integrated EssilorLuxottica/Alcon/CooperVision with ~47% of the broadest proxy's revenue in wholesale; FTC Contact Lens Rule and 2024 Eyeglass Rule; VSP Vision–Marcolin completed Dec 2025; Vision Council optical market $69.5B in 2025 with units and exams down). 2022–2026.
9. Histometrics child primer 42341 / U.S. Census NAICS 423410 — Photographic Equipment and Supplies Merchant Wholesalers (sales, cost of goods sold, gross margin, and concentration ratios all suppressed or unpublished at this code; ~$5.58B of purchases by merchant wholesalers excluding manufacturers' sales branches; 485 establishments and 6,620 employees, CBP 2023; captive manufacturer arms; CIPA global camera shipments 121.5M in 2010 vs 9.44M in 2025, +11.2% YoY with interchangeable-lens units +2.8%; 2025 tariffs including 10%→19% on Thailand/Malaysia production). 2022–2026.
10. U.S. Small Business Administration, Table of Small Business Size Standards (NAICS 4234 children: 100 employees for 423440 up to 250 for 423430, with 423410/423420/423450 at 200, 423460 at 175, and 423490 at 150), 2023. https://www.sba.gov/document/support-table-size-standards